Furthermore, plasma PAI-1 levels are elevated in patients with mild cognitive impairment and during the early stage of Alzheimer disease22, and increased PAI-1 expression has been observed near amyloid deposits or sites with inflammatory responses in the brains of patients with AD23. This evidence concerns the gene SERPINE1 and Cognitive impairment.